Twice-Weekly Brincidofovir (CMX001) Shows Promising Antiviral Activity in Immunocompromised Transplant Recipients With Asymptomatic Adenovirus Viremia
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2013.12.120
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2014
Authors
Publisher
Elsevier BV